Endonovo Therapeutics Inc (ENDV)

[Tkmoney1]

Catch 22 here. Obviously nice to hear from the company, but this also signals to the flippers/shorts/day traders, that results are still a little ways off. Which is why the sell off this morning. People looking to get back in at a lower price plain and simple. Anticipation and build-up started with the pump a couple of months ago, probably a bit premature, and when we got closer to the end of 2Q it was fairly obvious we were not getting results. So, in the short run looks like there might be a lot of pain, but things can change quickly and now it will be almost impossible to judge when those pre-clinical trial results will come.